Skip to main content
logo
Knight Therapeutics Inc. (FRA:04K)
Germany flag Germany · Delayed Price · Currency is EUR
3.720
0.00 (0.00%)
At close: Nov 28, 2025

Knight Therapeutics Revenue

Knight Therapeutics had revenue of 121.55M CAD in the quarter ending September 30, 2025, with 31.74% growth. This brings the company's revenue in the last twelve months to 413.85M, up 18.70% year-over-year. In the year 2024, Knight Therapeutics had annual revenue of 371.30M with 13.13% growth.

Revenue (ttm)
413.85M CAD
Revenue Growth
+18.70%
P/S Ratio
1.46
Revenue / Employee
555.50K CAD
Employees
745
Market Cap
370.20M EUR

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024371.30M43.11M13.13%
Dec 31, 2023328.20M34.64M11.80%
Dec 31, 2022293.56M50.09M20.57%
Dec 31, 2021243.48M43.96M22.03%
Dec 31, 2020199.52M152.06M320.39%
Dec 31, 201947.46M34.96M279.69%
Dec 31, 201812.50M3.87M44.78%
Dec 31, 20178.63M2.69M45.35%
Dec 31, 20165.94M4.90M472.81%
Dec 31, 20151.04M672.00K184.11%
Dec 31, 2014365.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Mercedes-Benz Group AG136.97B
Bayerische Motoren Werke Aktiengesellschaft136.42B
Deutsche Telekom AG121.02B
Allianz SE105.02B
Siemens Aktiengesellschaft78.91B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München62.10B
Siemens Energy AG39.08B
SAP SE36.49B
Revenue Rankings

Knight Therapeutics News

More News